| Title | Geography | Industry | ||||
|---|---|---|---|---|---|---|
| Number of ongoing Clinical Trials (for drugs) involving Pneumonia by Phase | Other Industry Indicators | Austria | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Cystic Fibrosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Allergic Rhinitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Sleep Apnea by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pulmonary Fibrosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Snoring by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Asthma by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Emphysema by Phase | Other Industry Indicators | Argentina | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bronchiectasis by Phase | Other Industry Indicators | Russia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Idiopathic Pulmonary Fibrosis by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Respiratory Distress Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Nasal Congestion by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pneumoconiosis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Empyema by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Respiratory Failure by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Community Acquired Pneumonia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bronchiolitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Breathing Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Apnea by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Chronic Obstructive Pulmonary Disease (COPD) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pleural Disease by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Lung Disease by Phase | Other Industry Indicators | Greece | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bronchospasm by Phase | Other Industry Indicators | Turkey | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Lung Injury by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hepatopulmonary Syndrome by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Silicosis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Perennial Allergic Rhinitis by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Apnea of Prematurity by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Respiratory Tract Inflammatory Disorders by Phase | Other Industry Indicators | Thailand | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Lower Respiratory Tract Infections by Phase | Other Industry Indicators | Estonia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Mixed Sleep Apnea by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Asbestosis by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Upper Respiratory Tract Infections by Phase | Other Industry Indicators | Philippines | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Acute Respiratory Failure by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Streptococcal Pneumonia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Alveolitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypoxia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Viral Bronchiolitis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Diaphragmatic Hernia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Adult Respiratory Distress Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pleurisy by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Atelectasis by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Chronic Respiratory Failure by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Respiratory Insufficiency by Phase | Other Industry Indicators | Austria | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Ventilator Associated Pneumonia (VAP) by Phase | Other Industry Indicators | India | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Cough by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Chronic Asthma by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Primary Ciliary Dyskinesia by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bronchiolitis Obliterans by Phase | Other Industry Indicators | Germany | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer